美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
LAMIVUDINE; STAVUDINE; NEVIRAPINE	021969	001	NDA	LAMIVUDINE; STAVUDINE; NEVIRAPINE	TABLET; ORAL	150MG; 30MG; 200MG	No	No	2006/11/17 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; STAVUDINE; NEVIRAPINE	021969	002	NDA	LAMIVUDINE; STAVUDINE; NEVIRAPINE	TABLET; ORAL	150MG; 40MG; 200MG	No	No	2006/11/17 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; STAVUDINE	021974	001	NDA	LAMIVUDINE; STAVUDINE	TABLET; ORAL	150MG; 30MG	No	No	2007/01/19 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; STAVUDINE	021974	002	NDA	LAMIVUDINE; STAVUDINE	TABLET; ORAL	150MG; 40MG	No	No	2007/01/19 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; STAVUDINE	022085	001	NDA	LAMIVUDINE; STAVUDINE	TABLET; ORAL	150MG; 30MG	No	No	2007/11/02 (TA)	--	MATRIX LABS	None (Tentative Approval)
LAMIVUDINE; STAVUDINE	022085	002	NDA	LAMIVUDINE; STAVUDINE	TABLET; ORAL	150MG; 40MG	No	No	2007/11/02 (TA)	--	MATRIX LABS	None (Tentative Approval)